Research libraryMOLEKUL / SOURCE RECORD

[Results of a clinical study of a new anxiolytic, a blocker of central cholecystokinin receptors].

Neznamov GG, Dorofeeva OA, Metlina MV, Syunyakov TS, Minaev SV, Ivashkina NY, Martyanov VA, Seredenin SB · 2019 · Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Uncontrolled human reportEnglish abstractSource linked
This is Molekul’s research summary, not the original publication. Educational information only, not medical advice. Seek qualified healthcare help for medical conditions.

What does this source report?

A 31-patient, 21-day GAD pilot reported improvements in anxiety and selected cognitive measures. The abstract does not establish randomized blinded control or superiority to standard treatments.

Population and setting
31 adults with generalized anxiety disorder
Evidence type
Uncontrolled human report
Preparation
See the original report; formulation details require verification.
Source language
English indexed abstract; original language: rus
Title provenance
Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.

What are the limitations?

  • Uncontrolled pilot evidence; expectancy and repeated-testing effects remain possible.
  • Later 25-patient conference analyses may overlap and are not counted as independent replication.

Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.

Review depth: Abstract reviewed

Source access and review scope

Primary publication metadata and indexed abstract checked via Europe PMC; full methodological review pending.

Recorded source-check date: 2026-10-05. This date does not imply a completed systematic review.

Open original source or index record ↗

DOI: 10.17116/jnevro201911908153

Cite and trace this record

Original source: Neznamov GG, Dorofeeva OA, Metlina MV, Syunyakov TS, Minaev SV, Ivashkina NY, Martyanov VA, Seredenin SB. [Results of a clinical study of a new anxiolytic, a blocker of central cholecystokinin receptors]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 2019.

Molekul research summary: https://molekul.io/research/rp-31626171. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.

Bibliography entry

Related compound profiles

Editorial policy and evidence standards